TheProfitWatch

FATE - Fate Therapeutics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.51 0.01 (0.66%) --- --- 0.01 (0.65%) -0.01 (-0.66%) 0.01 (0.66%) 0.03 (2.01%) 0.03 (2.01%)

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.29
Diluted EPS:
-0.29
Basic P/E:
-5.241
Diluted P/E:
-5.241
RSI(14) 1m:
100.0
VWAP:
1.52
RVol:

Events

Period Kind Movement Occurred At

Related News